News

The ballooning obesity drug market may have a new contender after Roche struck a $5.3 billion deal to develop Danish ...
Though retrospective, the findings provide ‘compelling’ evidence that GLP-1 receptor agonists may help prevent development ...
Plans to convert a former YMCA hall into a fish and chips shop have been withdrawn after concerns were raised by public ...
Use of antibiotics between birth and 2 years of age was associated with a 20% increased risk for childhood obesity.
The Danish drugmaker is expanding Wegovy access via telehealth providers like Hims and Ro. But the gap with Eli Lilly is only ...
A new study found more than two-thirds of Reserve and Guard troops are overweight, prompting a scathing rebuke of lax ...
The pecking order of the obesity drug market is shifting. Eli Lilly , the $815 billion maker of blockbuster weight-loss drugs ...
Novo Nordisk has launched its hugely popular weight-loss drug Wegovy in Thailand, an executive of the Danish drugmaker's ...
Obesity and diabetes are closely linked, but the good news is that both are preventable and manageable with early ...
Hardworking Tennesseans have tried changes to diets and exercise to lose weight and maintain healthy lifestyles, but ...
Adults who developed severe obesity before the age of 18 are nearly three times more likely than those who developed the ...
The obesity drug price wars are finally starting. After being publicly lambasted for the high cost of their weight-loss shots ...